Hepatocellular carcinoma

• An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo … Not authorised
  2024-514496-18-00 3 "Hepatocellular carcinoma, renal cell carcinoma and different"
• A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, a … Pending
  2025-523590-42-00 7 "Locally Advanced or Metastatic Solid Tumors"
• A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab. Recruiting
  2025-521639-34-00 3 2026-04-20 "• Non-small cell lung cancer (Stage III, unresectable) • Sma"
• NEOADJUVANT ATEZOLIZUMAB AND ADJUVANT ATEZOLIZUMAB + BEVACIZUMAB IN COMBINATION WITH PERCUTANEOUS RADIOFREQUENCY ABLATION OF SMALL HCC: A MU … Recruiting
  2024-519113-59-00 4 2024-11-20
• A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications Recruiting
  2023-506227-29-00 3 2024-08-30 "locally advanced or metastatic solid tumors"
• Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion Recruiting
  2024-515456-20-00 4 2024-08-13 "Hepato carcinoma cancer"
• A Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors Recruiting
  2023-510275-64-00 9 2023-05-31 "Hepatocellular carcinoma, colorectal cancer, endometrial can"
• A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, … Recruiting
  2025-524136-19-00 1 2026-04-28 "Selected Advanced or Metastatic Solid Tumors"
• Phase III Study of Rilvegostomig in Combination withBevacizumab with or without Tremelimumab as First-lineTreatment of Hepatocellular Carcin … Recruiting
  2024-518210-81-00 5 2026-03-18 "Advanced Hepatocellular Carcinoma"
• Evaluating the roLe of Multiplexed PET Imaging in the detection and staging of hepatocellulaR carcinoma and gAstro-entero-pancreatic tumors: … Recruiting
  2024-519505-35-00 5 2026-02-02 "hepatocellulaR carcinoma"
• A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Compared to Oral Lenvatinib Capsul … Recruiting
  2024-518012-39-00 1 2025-09-22 "Squamous-Cell Non-Small Cell Lung Cancer"
• A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma Recruiting
  2024-519499-22-00 1 2025-08-04 "Advanced or Metastatic Hepatocellular Carcinoma"
• A first-in-human study to learn about the safety of BAY 3547926 and how well it works in participants with advanced liver cancer Recruiting
  2024-516615-25-00 1 2025-05-14 "hepatocellular carcinoma (HCC)"
• Is CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer? Recruiting
  2024-511435-10-00 1 2025-04-30 "Hepatocellular Carcinoma"
• Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting
  2023-509632-26-00 9 2025-02-11 "Recurrent or Metastatic Solid Tumors (endometrial cancer (EC"
• Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting
  2023-506604-18-00 1 2024-02-14 "Triple negative breast cancer"
• IMMUWIN - A Phase II study of immunotherapy with durvalumab (MEDI4736) and tremelimumab in combination with Y-90 SIRT for intermediate stage … Recruiting
  2024-513950-32-00 4 2020-12-15 "Intermediate stage hepatocellular carcinoma (HCC)"
• Paediatric Hepatic International Tumour Trial Recruiting
  2024-516110-38-00 5 2018-03-06 "Hepatoblastoma and Hepatocellular Carcinoma"
• SIERRA: Durvalumab and Tremelimumab as First Line Treatment in Participants with Advanced Hepatocellular Carcinoma Recruitment ended
  2022-502012-37-00 5 2023-10-06 "Advanced Hepatocellular Carcinoma"
• Master Protocol of Novel Immunomodulators as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobilia … Recruitment ended
  2022-502317-29-00 4 2023-07-12 "Advanced Hepatobiliary Cancer"
• A clinical study to compare Toripalimab (JS001) combined with Lenvatinib versus placebo combined with Lenvatinib as the 1st-line therapy for … Recruitment ended
  2024-514207-34-00 5 2021-07-08 "Advanced hepatocellular carcinoma (HCC)"
• Study to evaluate the safety and efficacy of nivolumab combined with ipilimumab as first-line (1L) therapy for participants with advanced HC … Recruitment ended
  2023-508635-31-00 5 2019-12-03 "Hepatocellular Carcinoma"
• A Study of Atezolizumab (Anti-PD-L1 Antibody) plus Bevacizumab versus Active Surveillance as Adjuvant Therapy in Patients with Hepatocellula … Recruitment ended
  2023-504303-86-00 5 2019-11-21 "High-risk hepatocellular carcinoma (HCC)"
• A Phase 3 Study of Nivolumab versus Placebo for Participants with Hepatocellular Cancer Who Are at High Risk of Recurrence after Hepatic Res … Recruitment ended
  2023-508726-10-00 5 2018-03-28 "Hepatocellular Carcinoma"

Showing 1–24 of 41 trials